Debt-to-equity of Vitro Biopharma, Inc. from 31 Jul 2014 to 31 Oct 2025

Taxonomy & unit: ratio: %
Description: Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary: Vitro Biopharma, Inc. quarterly Debt-to-equity in % history and change rate from 31 Jul 2014 to 31 Oct 2025.
Vitro Biopharma, Inc. Debt-to-equity for the quarter ending 31 Oct 2025 was -138%, a 28% increase year-over-year.

Debt-to-equity, Quarterly (%)

Debt-to-equity, YoY Quarterly Change (%)

Vitro Biopharma, Inc. Quarterly Debt-to-equity (%)

Period	Value	YoY Chg	Change %	Date
Q3 2025	-138%	+55%	+28%	31 Oct 2025
Q2 2025	-145%	+98%	+40%	31 Jul 2025
Q1 2025	-156%	+188%	+55%	30 Apr 2025
Q4 2024	-170%	+642%	+79%	31 Jan 2025
Q3 2024	-192%	-1699%	-113%	31 Oct 2024
Q2 2024	-242%	-706%	-152%	31 Jul 2024
Q1 2024	-344%			30 Apr 2024
Q4 2023	-812%			31 Jan 2024
Q3 2023	1506%			31 Oct 2023
Q2 2023	463%			31 Jul 2023
Q3 2015	-105%	+1.2%	+1.1%	31 Oct 2015
Q2 2015	-105%	+1%	+0.95%	31 Jul 2015
Q1 2015	-105%			30 Apr 2015
Q4 2014	-105%			31 Jan 2015
Q3 2014	-106%			31 Oct 2014
Q2 2014	-106%			31 Jul 2014

* An asterisk sign (*) next to the value indicates that the value is likely invalid.